Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

605 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A case of the iatrogenic transmission of vascular Aß40 amyloid.
Kawarabayashi T, Nakamura T, Takatama S, Miyamoto N, Iwai T, Naito I, Sugawara T, Ishizawa K, Hashimoto K, Amari M, Ikeuchi T, Kasahara H, Ikeda Y, Takatama M, Shoji M. Kawarabayashi T, et al. Among authors: ishizawa k. Amyloid. 2024 Oct 29:1-3. doi: 10.1080/13506129.2024.2419857. Online ahead of print. Amyloid. 2024. PMID: 39470140 No abstract available.
Assessing the effects of interprofessional education by hospital pharmacists on pharmaceutical students using a self-evaluation scale.
Aizawa F, Hamano H, Okada N, Yagi K, Goda M, Nawa H, Horinouchi Y, Nakamura T, Hakuno H, Shinomiya K, Zamami Y, Azuma M, Akaike M, Ishizawa K. Aizawa F, et al. Among authors: ishizawa k. J Pharm Health Care Sci. 2024 Oct 1;10(1):61. doi: 10.1186/s40780-024-00382-6. J Pharm Health Care Sci. 2024. PMID: 39354644 Free PMC article.
Statins ameliorate oxaliplatin- and paclitaxel-induced peripheral neuropathy via glutathione S-transferase.
Aizawa F, Kajimoto H, Okabayashi A, Moriyama D, Yagi K, Takahashi S, Sonoda Y, Shibata T, Goda M, Niimura T, Izawa-Ishizawa Y, Hamano H, Kawada K, Zamami Y, Ishizawa K. Aizawa F, et al. Among authors: ishizawa k. Neurochem Int. 2024 Nov;180:105863. doi: 10.1016/j.neuint.2024.105863. Epub 2024 Sep 21. Neurochem Int. 2024. PMID: 39307458 Free article.
Unveiling the association between fluoroquinolones and aortic diseases using real-world database analysis and pharmacological experiments.
Miyata K, Izawa-Ishizawa Y, Tsujinaka K, Nishi H, Itokazu S, Miyata T, Kondo M, Yoshioka T, Niimura T, Aizawa F, Yagi K, Sato M, Hyodo M, Hamano H, Kawada K, Chuma M, Zamami Y, Tsuneyama K, Goda M, Ishizawa K. Miyata K, et al. Among authors: ishizawa k. Biomed Pharmacother. 2024 Oct;179:117418. doi: 10.1016/j.biopha.2024.117418. Epub 2024 Sep 11. Biomed Pharmacother. 2024. PMID: 39265233 Free article.
Real-world retrospective analysis of immune checkpoint inhibitor therapy for relapsed or refractory Hodgkin's lymphoma.
Oyake T, Maeta T, Takahata T, Tamai Y, Kameoka Y, Takahashi N, Miyairi Y, Murai K, Shimosegawa K, Yoshida K, Inokura K, Fukuhara N, Harigae H, Sato R, Ishizawa K, Tajima K, Saitou S, Fukatsu M, Ikezoe T, Tsunoda S, Mita M, Mori J, Kowata S, Ito S. Oyake T, et al. Among authors: ishizawa k. J Clin Exp Hematop. 2024 Sep 28;64(3):191-202. doi: 10.3960/jslrt.24021. Epub 2024 Jul 31. J Clin Exp Hematop. 2024. PMID: 39085129 Free PMC article.
Sequential Sampling of the Gastrointestinal Tract to Characterize the Entire Digestive Microbiome in Japanese Subjects.
Ishizawa K, Tamahara T, Suzuki S, Hatayama Y, Li B, Abe M, Aoki Y, Arita R, Saito N, Ohsawa M, Kaneko S, Ono R, Takayama S, Shimada M, Kumada K, Koike T, Masamune A, Onodera K, Ishii T, Shimizu R, Kanno T. Ishizawa K, et al. Microorganisms. 2024 Jun 28;12(7):1324. doi: 10.3390/microorganisms12071324. Microorganisms. 2024. PMID: 39065094 Free PMC article.
High levels of plasma neurofilament light chain correlated with brainstem and peripheral nerve damage.
Nakamura T, Kawarabayashi T, Shibata M, Kasahara H, Makioka K, Sugawara T, Oka H, Ishizawa K, Amari M, Ueda T, Kinoshita S, Miyamoto Y, Kaito K, Takatama M, Ikeda Y, Shoji M. Nakamura T, et al. Among authors: ishizawa k. J Neurol Sci. 2024 Aug 15;463:123137. doi: 10.1016/j.jns.2024.123137. Epub 2024 Jul 15. J Neurol Sci. 2024. PMID: 39032446 Free article.
Asciminib, a novel allosteric inhibitor of BCR-ABL1, shows synergistic effects when used in combination with imatinib with or without drug resistance.
Okamoto N, Yagi K, Imawaka S, Takaoka M, Aizawa F, Niimura T, Goda M, Miyata K, Kawada K, Izawa-Ishizawa Y, Sakaguchi S, Ishizawa K. Okamoto N, et al. Among authors: ishizawa k. Pharmacol Res Perspect. 2024 Aug;12(4):e1214. doi: 10.1002/prp2.1214. Pharmacol Res Perspect. 2024. PMID: 39031848 Free PMC article.
605 results